Directional and quantitative phosphorylation networks

Briefings in Functional Genomics and Proteomics

Volumn 7, Issue 1, 2008, Pages 17-26

  Jørgensen, Claus ^a,c   Linding, Rune ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Mass spectrometry; Network modelling; Phosphorylation; Prediction; Quantitation; Systems biology

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN SH2; PROTEIN TYROSINE KINASE;

ALGORITHM; CELL INTERACTION; DISEASE MODEL; ENZYME ASSAY; ENZYME ENGINEERING; FLOW CYTOMETRY; HUMAN; MACHINE LEARNING; MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; STATISTICAL MODEL;

COMPUTATIONAL BIOLOGY; MASS SPECTROMETRY; MODELS, BIOLOGICAL; NEOPLASMS; PHOSPHOPROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 44249108848     PISSN: 14739550     EISSN: 14774062     Source Type: Journal    
DOI: 10.1093/bfgp/eln001     Document Type: Review

References (59)

1. Diella F, Gould CM, Chica C, et al. Phospho.ELM: A database of phosphorylation sites update 2008. Nucleic Acids Res 2008;36 (Database issue)D240-4 [Epub 2007 Oct 25].
2. Olsen JV, Blagoev B, Gnad F, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006;127:635-48.
3. Schmelzle K, White FM. Phosphoproteomic approaches to elucidate cellular signaling networks. Curr Opin Biotechnol 2006;17:406-14.
4. Mann M, Ong SE, Gronborg M, et al. Analysis of protein phosphorylation using mass spectrometry: Deciphering the phosphoproteome. Trends Biotechnol 2002;20:261-68.
5. Witze ES, Old WM, Resing KA, et al. Mapping protein post-translational modifications with mass spectrometry. Nat Methods 2007;4:798-806.
6. Blagoev B, Kratchmarova I, Ong SE, et al. A proteomic strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 2003;21:315-18.
7. Blagoev B, Ong SE, Kratchmariva I, et al. Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat Biotechnol 2004;22:1139-45.
8. Pandey A, Podtelejnikov AV, Blagoev B, et al. Analysis of receptor signaling pathways by mass spectrometry: Identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. Proc Natl Acad Sci USA 2000;97:179-84.
9. Rush J, Moritz A, Lee KA, et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 2005; 23:94-101.
10. Zhang Y, Wolf-Yadlin A, Ross PL, et al. Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol Cell Proteomics 2005;4:1240-50.
11. Groenborg M, Kristiansen TZ, Stensballe A, et al. A mass spectrometry-based proteomic approach for identification of serine/ threonine-phosphorylated proteins by enrichment with phosphor-specific antibodies: Identification of a novel protein, Frigg, as a protein kinase A substrate. Mol Cell Proteomics 2002;1:517-27.
12. Matsuoka S, Ballif BA, Smogorzewska A, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007;316:1160-66.
13. Ficarro SB, McCleland ML, Stukenberg PT, et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol 2002;20:301-5.
14. Larsen MR, Thingholm TE, Jensen ON, et al. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics 2005;4 873-86.
15. Beausoleil SA, Jedrychowski M, Schwartz D, et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci USA 2004;101:12130-5.
16. Tao WA, Wollscheid B, O'Brien R, et al. Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry. Nat Methods 2005; 2:591-8.
17. 3+) affinity chromatography. Anal Biochem 1986;154 250-54.
18. Bodenmiller B, Mueller LN, Mueller M, et al. Reproducible isolation of distinct, overlapping segments of the phosphoproteome. Nat Methods 2007;4:231-7.
19. Wolf-Yadlin A, Kumar N, Zhang Y, et al. Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Mol Sys Biol 2006;2:54.
20. Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 2005;1:252-62.
21. Dengel J, Akimov V, Olsen J, et al. Quantitative proteomic assessment of very early signaling events. Nat Biotechnol 2007; 25:566-48.
22. Huang P, Mukasa A, Bonavia R, et al. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutics strategy for glioblastoma. Proc Natl Acad Sci USA 2007;104:12867-72.
23. Kumar N, Wolf-Yadlin A, White FM, et al. Modeling HER2 effects on cell behaviour from mass spectrometry phosphotyrosine data. PLoS Comput Biol 2007;3:e4.
24. Wolf-Yadlin A, Hautaniemi S, Lauffenburger DA, et al. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc Natl Acad Sci USA 2007;104 5860-5.
25. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assay for major plasma proteins. Mol Cell Proteomics 2006;5:573-88.
26. Cox DM, Zhong F, Du M, et al. Multiple reaction monitoring as a method for identifying protein posttranslational modifications. J Biomol Tech 2005;16:83-90.
27. Beausoleil SA, Villen SA, Gerber SA, et al. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 2006;24: 1285-92.
28. Syka JE, Coon JJ, Schroeder MJ, et al. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci USA 2004;101:9528-33.
29. Kelleher NL, Zubarev RA, Bush K, et al. Localization of labile posttranslational modification by electron capture dissociation: The case of gamma-carboxyglutamic acid. Anal Chem 1999;71 4250-53.
30. Molina H, Horn DM, Tang N, et al. Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Aci 2007;104:2199-204.
31. Miller ML, Jensen JL, Jørgensen FDC, et al. Linear motif atlas for phosphorylation-dependent signalling Nature Biotech 2008. Forthcoming.
32. Hutti JE, Jarrel ET, Chanq JD, et al. A rapid method for determining protein kinase phosphorylation specificity. Nat Methods 2004;1:27-9.
33. Yaffe MB, Leparc GG, Lai J, et al. A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol 2001;19:348-53.
34. Linding R, Jensen LJ, Ostheimer G, et al. Systematic discovery of in vivo phosphorylation networks. Cell 2007; 129:1415-26.
35. Allen JJ, Li M, Brinkworth CS, et al. A semisysthetic epitope for kinase substrates. Nat Methods 2007;4:511-16.
36. Depoure N, Howson RW, Blethrow JD, et al. Combining chemical genetics and proteomics to identify protein kinase substrates. Proc Natl Acad Sci USA 2005;102:17940-45.
37. Ubersax JA, Woodbury EL, Quanq PN, et al. Targets of the cyclin-dependent kinase Cdk1. Nature 2003;425:859-64.
38. Chen X, Ye H, Kuruvilla R, et al. A Chemical-genetic approach to studying neurotrophin signaling. Neuron 2005; 46:13-21.
39. Bishop AC, Ubersax JA, Petsch DT, et al. A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 2000; 407:395-401.
40. Irish JM, Kotecha N. Nolan GP. Mapping normal and cancer cell signaling networks: Towards single-cell proteomics. Nat Rev Cancer 2006;6 146-55.
41. Irish JM, Hovland R, Krutznik PO, et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004; 118:217-28.
42. Sheehan KM, Calvert VS, Kay EW, et al. Use of reversephase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 2005;4:346-55.
43. Nielsen UB, Cardone MH, Sinskey AJ, et al. Profiling receptor tyrosine kinase activation by using Ab microarrays. Proc Natl Acad Sci USA 2003;100:9330-5.
44. Engelman JA, Zejnullahu K, Mitsudomi T, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007;316:1039-43.
45. Stommel JM, Kimmelman AC, Ying H, et al. Coactivation of receptor tyrosine kinases affect the response of tumour cells to targeted therapies. Science 2007;318:287-90.
46. Janes K, Albreck JG, Gaudet S, et al. A systems model of signaling identified a molecular basis set for cytokines-induced apoptosis. Science 2005;310:1646-53.
47. Miller-Jensen K, Janes K, Brugge JS, et al. Common effector-processing mediates cell-specific responses to stimuli. Nature 2007;448:604-8.
48. Janes KA, Albreck JG, Peng LX, et al. A high-throughput quantitative multiplex kinase assay for monitoring information flow in signaling networks: Application to sepsis-apoptosis. Mol Cell Proteomics 2003;2:463-73.
49. Shults MD, Janse KA, Lauffenburger D, et al. A multiplexed homogeneous fluorescence-based assay for protein kinase assay in celll lysates. Nat Methods 2005;2:1-7.
50. Verveer PJ, Wouters FS, Reynolds AR, et al. Quantitative imaging of lateral ErbB1 receptor signal propagation in the plasma membrane. Science 2000;290:1567-70.
51. Yudushkin IA, Schleifenbaum A, Kinkhabwala A, et al. Live-cell imaging of enzyme-substrate interaction reveals spatial regulation of PTP1B. Science 2007;315:115-119.
52. Bakal C, Aach J, Church G, et al. Quantitative morphological signatures define local signaling networks regulating cell morphology. Science 2007;316:1753-6.
53. Elowitz MB, Levine AJ, Siggia ED, et al. Stochastic gene expression in a single cell. Science 2002;297:1183-6.
54. Barrios-Rodiles M, Brown KR, Ozdamar B, et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005;307:1621-5.
55. Rual JF, Venkatesan K, Hao T, et al. Towards a proteome-scale map of human protein-protein interaction network. Nature 2005;437 1173-8.
56. Gaudet S, Janes KA, Albeck JG, et al. A compendium of signals and responses triggered by prodeath and prosurvival cytokines. Mol Cell Proteomics 2005;4:1569-90.
57. Janes KA, Yaffe MB. Data-driven modeling of signal-transduction networks. Nat Rev Mol Cell Biol 2006;7: 820-8.
58. Reinhardt HC, Aslanian AS, Lees JA, et al. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/ MK2 pathway for survival after DNA damage. Cancer Cell 2007;11 175-89.
59. Shannon CE. A mathematical theory of communication. The Bell System Technical Journal 1948;27:379-423, 623-656.